CPC C12N 5/0638 (2013.01) [A61K 35/17 (2013.01); A61K 39/39 (2013.01); A61K 51/1042 (2013.01); C07K 14/70532 (2013.01); C07K 14/70578 (2013.01); C07K 14/70596 (2013.01); C12N 5/0603 (2013.01); C12N 5/0636 (2013.01); C12N 5/0694 (2013.01); C12N 5/10 (2013.01); G01N 33/505 (2013.01); G01N 33/56972 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/51 (2013.01); C12N 2501/515 (2013.01); C12N 2501/52 (2013.01); C12N 2510/00 (2013.01)] | 3 Claims |
1. A method of in vitro proliferating, γδ T cells, comprising:
stimulating isolated human PBMCs comprising γδ T cells with zoledronic acid and IL-2 for a first period to generate enriched γδ T cells, and then stimulating enriched γδ T cells in the isolated human PBMCs by co-culture with human leukocyte antigen (HLA) deficient feeder cells expressing 4-1BBL, CD80, CD83 and CD40L in the presence of IL-2 and without an anti-CD3 antibody for a second period to obtain proliferating γδ T cells,
wherein the feeder cells are prepared by transducing nucleic acids encoding a costimulatory molecule group consisting of 4-1BBL, CD80, CD83 and CD40L, into isolated K562 cells that do not express HLA.
|